CPHI Online is the largest global marketplace in the pharma ingredients industry

  • Products
    0
  • Companies
    0
  • Articles
    0
  • Events
    0
  • Webinars
    0

Formulation Development

Formulation Development
Product Description

Quotient Sciences has almost 30 years of experience developing a breadth of pharmaceutical formulations across a range of indications. Our innovative approach to formulation development integrates drug product development with clinical evaluation, combined with our experience with over 1,000 molecules at all stages of drug development.

- Formulations design 
- Pre-formulation screening
- First-in-human
- Solubility enhancement 
- Modified release
- Analytical Services 
- Process optimization & scale-up 
- Gamma scintigraphy

QUOTIENT SCIENCES LIMITED

  • GB
  • 2017
    On CPHI since
  • 500 - 999
    Employees
Company types
Academic/Research
Consultancy
Contract Service
Manufacturer/Innovator
Specifications
  • Supplied from
    United Kingdom; United States

QUOTIENT SCIENCES LIMITED

  • GB
  • 2017
    On CPHI since
  • 500 - 999
    Employees
Company types
Academic/Research
Consultancy
Contract Service
Manufacturer/Innovator

More Products from QUOTIENT SCIENCES LIMITED (16)

  • Translational Pharmaceutics - Integrated Programs

    Product Translational Pharmaceutics - Integrated Programs

    Translational Pharmaceutics® accelerates drug development by integrating formulation development, real-time manufacturing and clinical testing. The platform is unique to Quotient Sciences and has been used over the last decade by global pharmaceutical and biotech companies across over 400 drug programs. qq...
  • Oncology

    Product Oncology


    Supporting oncology drug development from candidate selection through to commercial manufacture and supply
    In the past 5 years alone, Quotient has successfully worked on over 300 oncology development projects for 91 different oncology drug candidates spanning 34 different disea...
  • Candidate Selection - Integrated Programs

    Product Candidate Selection - Integrated Programs

    Selecting the right molecules for development - Quickly identify the best drug candidates. Knowing what it takes to develop a successful drug, we help clients select the best molecules for development. Our unique integration of scientific capabilities enables us to provide a complete assessment o...
  • Early Stage Development - Integrated Programs

    Product Early Stage Development - Integrated Programs

    Accelerating molecules through to proof-of-concept - Simplify early development and accelerate to Proof-of Concept.Proof-of-concept (POC) is a key milestone in the development of a new drug candidate. We understand the transition to POC needs to be fast and cost-effective.With fully integrated capabil...
  • Late Stage Development - Integrated Programs

    Product Late Stage Development - Integrated Programs

    .Accelerating products through to commercial manufacture - Speed the journey from proof-of-concept to commercial launch. The journey from proof-of-concept to commercial launch can be complex. Speed is critical but it shouldn’t come at the expense of product quality. Creating patient-centric formulatio...
  • Drug Substance

    Product Drug Substance

    Our streamlined approach to developing drug substance has been shown to reduce manufacturing costs by 50% from preclinical to Phase I.  To best support our customer’s needs, we have made significant investments in technologies and equipment to meet the increasing demand for complex small-scale dr...
  • Clinical Trial Manufacturing

    Product Clinical Trial Manufacturing

    Understanding that early phase clinical testing is a pivotal milestone in the development of your drug product, Quotient offers a clinical trial manufacturing, testing and certification service designed to meet your individual requirements. Our innovative method of building integrated GMP and GCP programs ...
  • Commercial Manufacturing

    Product Commercial Manufacturing

    Quotient Sciences is a global player in commercial drug product manufacture of small molecule products for niche therapies including oncology and orphan drugs. Our commercial manufacturing facility located in Philadelphia is designed to handle your high-potency compounds.
    Our commercial batch ...
  • Clinical Pharmacology

    Product Clinical Pharmacology

    When you are looking for a partner who is dedicated to Phase I trials and early clinical development, rely on Quotient Sciences for the experience and expertise to seamlessly deliver your studies with the highest quality service and speed. We accelerate your molecule from first-in-human to proof-of-concept...
  • Bioanaysis

    Product Bioanaysis

    Delivering rapid bioanalytical data in discovery – preclinical – clinical. Bioanalysis is a critical step in the drug development process.  At Quotient, we are experts in the development, validation, and application of bioanalytical assays.  
    Our dedicated team of bioanalytical chemists...
  • Data Sciences

    Product Data Sciences

    You need data rapidly to make crucial decisions during a study. Faster data means we can provide our customers with earlier interim data and interim PK reports for on-study dosing and formulation decisions.
    We understand on-study changes to early phase study designs and d...
  • Drug Development Consulting

    Product Drug Development Consulting

    Our Drug Development Consultants work with you to design and implement successful drug development programs. With industry leading scientific expertise across a range of technical disciplines, we help customers across all stages of development, from candidate selection to commercial launch.

    Our cons...

QUOTIENT SCIENCES LIMITED resources (25)

  • News CPHI Milan 2024: Excerpts from the Exhibitors

    After another successful year of bringing the pharmaceutical community together at CPHI Milan in October, hear direct from the exhibitors on why the event is so important for them and the industry as a whole. 
  • Technical Data Formulation Development at Quotient

    Quotient Sciences has almost 30 years of experience developing a breadth of pharmaceutical formulations across a range of indications. Our innovative approach to formulation development integrates drug product development with clinical evaluation, combined with our experience with over 1,000 molecules at all stages of drug development. 
  • News Quotient Sciences acquires UK-based CDMO Arcinova

    With over 40 years of experience and 160 employees, Arcinova provides drug substance, drug product and bioanalysis services to over 200 pharma and biotech customers worldwide
  • Technical Data Clinical Pharmacology at Quotient

    When you are looking for a partner who is dedicated to Phase I trials and early development,rely on Quotient Sciences. 

    We accelerate your molecule from first-in-human to proof-of-concept,helping you make critical decisions earlier. 
    Whatever clinical pharmacology study you require, you can expect a fully integrated program from study design to data reporting.
  • News Quotient Sciences Completes Million Dollar Pharmacy Expansion at Miami Clinic

    Miami, FL/June 22, 2020 - Quotient Sciences, a global pharmaceutical development, clinical and commercial manufacturing organization, announced today the completion of a $1 million dollar pharmacy and laboratory expansion at their Miami, FL clinical pharmacology facility. 


    The expanded pharmacy capabilities offer customers a quick and cost-effective way to start clinical testing, without the need for extensive CMC investment or API consumption at this early stage of development.
  • Technical Data Global Formulation & Manufacturing Capabilities

    With over 30 years’ experience, Quotient Sciences provides full service support for small molecule non-sterile programs, from dosage formulation development through to GMP clinical trial manufacturing and commercial drug product supply.
  • News Quotient Sciences and CytoAgents Accelerate Potential Treatment for COVID-19 Cytokine Storm

    Collaboration Expedites Human Clinical Trials for COVID-19 Drug Candidate. A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials was announced today [April 28, 2020] by Quotient Sciences, a leading provider of innovative drug development and manufacturing solutions, and CytoAgents, Inc. a privately help biotechnology company focused on the development of pharmaceutical products for treatment of infectious diseases.
  • Technical Data Clinical Trial Manufacturing at Quotient

    Understanding that early phase clinical testing is a pivotal milestone in the development of your drug product, Quotient offers a clinical trial manufacturing, testing and certification service designed to meet your individual requirements. 

    Our innovative method of building integrated GMP and GCP programs provides you with a streamlined, flexible approach to drug product supply that reflects your clinical study design and timeline. 


    We understand the time and cost pressures you face during early phase evaluation and work with you to ensure a rapid, seamless path from development to clinical trial supply.
  • News ANA Therapeutics and Quotient Sciences Announce Partnership to Manufacture Niclosamide Drug Candidate as a Potential Treatment for COVID-19 Collaboration

    ANA Therapeutics, a Silicon Valley-based biotech startup, and Quotient Sciences, a leading provider of innovative drug development and manufacturing solutions, today announced a partnership to support the manufacturing of ANA Therapeutics’ drug candidate, ANA001 (niclosamide capsules), which they are developing as a potential treatment for COVID-19.
  • Technical Data Commercial Manufacturing at Quotient

    Pharmaceutical commercial manufacturing - Quotient Sciences is a global player in commercial drug product manufacture of small molecule products for niche therapies including oncology and orphan drugs. 
    Our commercial manufacturing facility located in Philadelphia is designed to handle your high-potency compounds.
  • Technical Data Pediatric Development at Quotient

    Pediatric formulation and product development
    The development of acceptable, palatable pediatric formulations is a key feature within the industry today, driven by patient needs and regulatory requirements. 

    Quotient Sciences has extensive knowledge and capabilities that enable us to provide you with a unique integrated pediatric development solution.

  • Technical Data Taste Masking at Quotient

    Many drug substances are extremely bitter or have other aversive attributes,which can make developing palatable drug products extremely challenging.This is a common problem seen in medicines spanning all therapeutic areas,from antibiotics and painkillers to antihistamines and decongestants. The careful design and development of formulated oral drug products is key to ensuring patient acceptability and compliance for achieving the desired clinical outcomes.
  • Technical Data 505(b)(2) Product Development at Quotient

    Are you developing a new dosage form for an existing drug? 

    Do you need to explore a different route of administration?

    Quotient has significant experience in 505(b)(2)product development and can support you in efficiently turning your innovative ideas into successful products.Over the past several years, the FDA’s 505(b)(2)regulatory pathway has enabled the approval of a variety of differentiated dosage forms for existing molecules
  • Technical Data Translational Pharmaceutics - a Quotient Innovation

    Translational Pharmaceutics® accelerates drug development by integrating formulation development, real-time manufacturing and clinical testing. The platform is unique to Quotient Sciences and has been used over the last decade by global pharmaceutical and biotech companies across over 400 drug programs.
  • Technical Data PBPK Modelling and Simulation at Quotient

    Quotient is a leading expert in the application of physiologically based pharmacokinetic (PBPK) modelling and simulation (M&S) science to drug development. 

    Using GastroPlus™ we advise our clients on the potential in vivo performance of drugs and formulations to inform product and clinical development strategies. 


    Whether working in a consultancy relationship or as part of an integrated program of work, our PBPK expertise is underpinned by our unique and extensive experience in pharmaceutics, biopharmaceutics, DMPK and clinical research.
  • Technical Data Pre-formulation & Material Sciences at Quotient

    Providing expertise to support pre-formulation development

    Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
  • Technical Data Compounding and GMP Manufacturing for Product Supply at Quotient

    Quotient Sciences provides integrated pharmacy compounding, formulation, GMP manufacturing and clinical testing solutions to help clients achieve their proof-of-concept (POC) milestone quickly, saving them precious development time and money.  

    Begin your First-in-Human (FIH) Phase I testing with a fit-for-purpose, simple pharmacy preparation, and then seamlessly transition to a scalable, solid oral GMP drug product for Phase II trials, all within one organization.
  • Technical Data Inhaled Product Development at Quotient

    With more than 30 years’ experience, Quotient is a leader in the development, manufacture and assessment of inhalation products, helping clients to accelerate molecules from first-in-human through to proof-of-concept. 

    Our integrated capabilities and vast knowledge encompasses pre-formulation sciences, formulation development, device evaluation, clinical trial manufacturing and the clinical assessment of a variety of inhaled formats for nasal and pulmonary delivery.
  • Technical Data High Potency Handling at Quotient

    High Potency Drug Development & Manufacturing

    Highly potent active pharmaceutical ingredients (HPAPIs) are becoming increasingly common in drug development pipelines, especially in the oncology sector, as researchers search for therapies with greater selectivity and pharmacological activity. However, HPAPIs present additional CMC challenges due to the containment requirements to protect both the operators and manufacturing facilities. Their production processes may also require greater precision and control due to the very small quantities of drug present in the final dosage form.
  • Technical Data Human ADME Studies at Quotient

    Whatever your requirements, Quotient Sciences can support you in the generation of clinical metabolism data for your drug development program and for NDA, MAA and global regulatory filings.
  • Technical Data First-in-human to Proof-of-Concept at Quotient

    Quotient Sciences’ Translational Pharmaceutics® approach enables First-in-Human studies by re-engineering the transition of your drug molecule into clinical development and shortening the timeline to Proof-of-Concept.

    How? Quotient’s Translational Pharmaceutics® platform integrates formulation development, real-time adaptive GMP manufacturing and clinical testing so that drug product manufacture occurs immediately prior to dosing.Each manufacture of drug product is therefore conducted in response to emerging clinical data. This approach delivers significant benefits to the development team.
  • Technical Data Spray Drying at Quotient

    Overcoming poor drug solubility and bioavailability challenges

    Drug solubility has a significant impact on bioavailability. 70% of new chemical entities (NCEs) suffer from low aqueous solubility that can result in failure during clinical testing due to poor bioavailability. Selecting an appropriate drug formulation is imperative to the success of the program.
  • Technical Data Project Management at Quotient

    Project Management at Quotient – A True Partnership
    Quotient is an innovative drug development and manufacturing partner supporting clients from candidate selection to commercial launch. With expertise in end-to-end Project Management and integrated project teams, we make drug development easier for our customers and dramatically reduce the time and cost of getting new medicines to patients.
  • Video John McDermott, Quotient Sciences, discusses the unique benefits of Translational Pharmaceutics

    John McDermott, Executive Director, Drug Development Solutions - Quotient Sciences discusses Translational Pharmaceutics at CPHI Worldwide, and how a recent Tufts study has proven the significant savings and financial benefits for drug developers who use Translational Pharmaceutics.
  • Technical Data Formulation Strategies for Poorly Soluble Molecules at Quotient

    As the number of poorly soluble compounds continues to increase in the industry development pipeline, conventional formulation strategies may not be sufficient to achieve acceptable levels of solubility in the gastrointestinal tract and hence absorption into the systemic circulation. Scientists will need to utilize advanced formulation technologies to maximize oral bioavailability.

Frequently Viewed Together

  • Product Formulation Development

    Within early development, there are a variety of different challenges that hinder a molecule's ability to progress to the next phase such as complex formulation.

    The complexity of formulation development has been on the rise, which is driven by a variety of different factors including:

    ...
  • Product Labrafac MC60

    Labrafac™ MC60 (glycerol monocaprylocaprate) is a water-insoluble surfactant used in oral lipid-based formulation for bioavailability enhancement of poorly water-soluble, and poorly permeable drugs. It acts as a solubilizer and as an intestinal permeation enhancer.
  • Product STOMATOVIS LINE - Innovative protection fo the mouth

    Treatment and prevention of aphtae, aphtous stomatitis, small lesions from trauma, gingivitis. Two different presentations: • STOMATOVIS PROTECTIVE STOMATOLOGICAL PASTE, Medical Device class IIb, Presentation: 5 ml Tube • STOMATOVIS MOUTHWASH,  Medical Device class IIb, Presentation: 200 ml Bottle q...
  • Product R&D and Industrialization

    We specialise in research and development in the ophthalmic field for multinationals, Italian as well as international pharmaceutical companies. For them, we develop, fine-tune and manufacture, in aseptic conditions, pharmaceuticals and sterile medical devices for topical use in differen...
  • Product OralogiK™ - Controlled release technology

    BDD has developed an erosion based controlled release technology that provides unrivaled control of drug release at a pre-defined time with no release of drug prior to the pulse. The technology is an erodible barrier layer that is wrapped around a drug containing core to give a tablet in tablet dose form. ...
  • Product Pharmaceutical R&D Services

    Having decades of hands-on experience on a wide range of (complex) technologies and a many different types of products, our Pharmaceutical experts are able to fully execute and/or support the development of any finished dosage form, formula or process, as well as the transfer and scale-up of a deve...
  • Product Early stage formulation Development & Process Design

    We have extensive experience in solving complex formulation challenges. Our experts can apply our extensive range of proprietary technologies for immediate (IR) and modified (MR) / sustained, slow (SR) / controlled (CR) / extended (XR, ER) / pulsed / timed release as well as enteric and gastro reten...
  • Product Extended release microparticle formulations

    MJR PharmJet supplies extended release parenteral formulations with biodegradable polymers.
  • Product Tablets, bolus and effervescent tablets

    Dry forms : tablets, effervescent tables, bolus, powders ... filled in specific packaging according to species, product, dosage, use : plastic bottle, aluminium pouch
  • Product Recipharm Inhalation Solutions™

    Recipharm Inhalation Solutions™ offers an end-to-end service for inhalation drug products and devices spanning early stage development to commercial manufacture.Our dedicated team offers pharmaceutical companies a seamless outsourcing service from early stage development through to commercial manufacturing...
  • Product APIs

    API are offered from US FDA/EU GMP/ COFEPRIS MEXICO/KFDA/WHO GENIVA approved facility. 
  • Product R&D and Industrialization

    We specialise in research and development in the ophthalmic field for multinationals, Italian as well as international pharmaceutical companies. For them, we develop, fine-tune and manufacture, in aseptic conditions, pharmaceuticals and sterile medical devices for topical use in different fo...
  • Product Spray-drying

    Spray-drying is an instant and continuous solvent evaporation process of a liquid feed, atomised in a heated gas, generating a final dried solidified particle.The heated drying gas moves in co-flow with the atomised feed in the process chamber where the gas transfers its heat energy to the droplets and abs...
  • Product CordenPharma Derivatized Phospholipids - DPPC & More

    CordenPharma's expert lipid manufacturers have mastered the chemical total synthesis of complex phospholipid derivatives from multi-gram to multi-kilogram scale and are renowned for their contract lipid and phospholipid molecule manufacturing expertise. Our large-scale proprietary cGMP manufacturing proces...
  • Product VELOXTAR™ technology

    VELOXTAR™ is a technology that produces a very thin orally disintegrating tablet (ODT) like a coin. The distinctive tablet shape and unique formulation design allow the ODTs to disintegrate in 4-6 seconds. VELOXTAR™ technology significantly reduces the disintegration time, while still providing practical t...
  • Product Complex Semi-synthetic APIs

    Micafungin Sodium, Anidulafungin-Fructose, Dalbavancin, Everolimus, Sarecycline, Midostaurin etc.
  • Product Continuous Manufacturing of Formulations in Minutes Instead of Hours

    Microinnova Engineering GmbH has successfully commissioned two continuous formulation production plants for a European client. The design of the fully automated plant is very compact, which makes it possible to easily transport & install it at a different manufacturing site on the other side of the wor...
  • Product Martindale: The Complete Drug Reference

    The world's most comprehensive reference source about drugs and medicines. 
    The expertly curated information includes over 7,600 drug monographs, over 200,000 preparations from 43 countries and regions and over 25,000 international manufacturers and distributors.
    Find out more about ...
  • Product Grindeks FDF portfolio

    Please see Grindeks up-to-date Final Dosage Form (FDF) product portfolio, including pipeline products, in the link attached. Dossiers are harmonized according to ICH and EMA requirements. https://grindeks.com/en/products/final-dosage-forms/
  • Product Inhaled Formulation Development

    With expertise in powder and liquid formulations for small molecules and biologics, as well as a broad portfolio of proprietary device and formulation technologies, we can help you overcome the challenges of inhaled formulation development.

    Dry Powder Formulation
    Advanced po...
  • Product Lifetech™ SpinChem® MagRBR

    A magnetic, rotating bed reactor, pre-packed with a variety of Lifetech™ ECR resins. Designed for parallel laboratory development and reaction screening in 5 – 100 mL volumes enabling easier and faster screening and optimization of biocatalysis production processes. Developed in collabortion with SpinChem.
  • Product IND Enabling Preformulation Package (IEPP)

    WuXi STA's IND Enabling Pre-formulation Package (IEPP) is an integrated and end-to-end developability assessment service for new chemical entities (NCE's). Through this comprehensive service, you can efficiently identify challenges and tailored solutions earlier for higher project success rates and lower o...
  • Product SAFFROX

    100% Natural Multifunctional Antidepressant Saffrox™ is a new 100% natural advanced antidepressant composed of Saffron, turmeric, magnesium and vitamins. Studies shows efficacy same as Prozac(1) a Selective Serotonin Reuptake Inhibitor (SSRI), or Imipramine(2) but without the side effects of the ...
  • Product Formulation and Analytical Solutions

    GVK BIO offers a range of Formulation R&D solutions that include pre-formulation studies, formulation development, analytical R&D, reformulation and stability studies. We can also support clinical supplies and manufacturing of exhibit batches in collaboration with our partners and offer standalone ...
  • Product VetaFilmTM - Veterinary Oral Film Technology

    VetaFilm™ is our proprietary veterinary oral film technology that provides significant market opportunities to improve drug delivery for companion animals. VetaFilm™ research and development services and veterinary oral films provide: • Dose placed directly on oral mucosa or on their f...
  • Product Formulation & Development

    From brand new products to existing ones in need of new revenue streams, or a reliable and efficient producer, benefit from our years of pharmaceutical experience and let us help you get your product to market. We are focused on helping our customers move from early-stage development to commercialization a...
  • Product Formulation Development including Inhaled Products

    Inhaled products and formulation development: The development of drugs using experimental design approaches with integrated stability testing and storage is available from us. Our formulation specialists can provide a wide range of formulations in a timely and cost-effective manner in order to identify t...
  • Product Development Service

    Lomapharm GmbH provides wide range of services which includes development service. It provides the whole range of control services - from raw material testing to stability testing according to GMP and ICH regulations. One of the main areas of competence and experience is also available for galenic dev...
  • Product UniLayer - 200mg Ibuprofen

    This product is suitable for children as a delivery system. 

    Must be taken with water or beverage of choice. 


    We are looking for partner on a CDMO bases. 
  • Product GALENIC DEVELOPMENT

    TECNALIA, experts in Pharmaceutical Development, Scale-up & Pilot Batches Manufacturing, Clinical Trials and Contract Manufacturing

    GALENIC DEVELOPMENT
    • Preformulation studies.
    • Design and galenic develop...
  • Product Pharmaceutical Development - Early Phase

    Almac's experienced formulation scientists can develop a range of oral dose formulations for early stage clinical trials.

    With both non-GMP and GMP facilities, flexible and efficient solutions are provided to develop a fit-for-purpose formulation for your early phase clinical trial.
    ...
  • Product Formulation Development

    Formulation & process development of complex oral solids drug products. Specialized in solubility enhancement, drug delivery, controlled release, functional coating, granulation, pellets & micropellets. From technical feasibility to GMP for clinical trials and commercial manufacturing.Core compente...
  • Product Aseptic fill and finish

    We offer solutions for companies that need CMO capacity concerning the aseptic filling of syringes and assembly and packaging of pre-filled syringes and auto-injectors. We will enhance your product by adding value through manufacturing if you require additional capacity or a complete technology transfer. q...
  • Product Pharmacokinetic modeling

    The SurroGUT™ platform is a powerful tool for developing advanced predictive Physiologically Based Biopharmaceutics (PBB) models and mechanistic in vitro–in vivo correlations (IVIVCs). It uniquely combines TIM dissolution experiments, TIM gastrointestinal fluids, cell-based microfluidics, and GastroPlus® s...
  • Product Pulmonary Delivery

    Where particle size and performance really matters, Upperton have the expertise.
    Drug delivery into the lung is one of the fastest growing, yet technically challenging areas of pharmaceutical development. Producing a successful pulmonary drug product requires expertise in formulation development, part...
  • Product Functional film coating

    Easy, fast and reliable enteric protection? Why not! - High performance protection against acidic conditions. - Suitable for granules, pellets, tablets and capsules. - For pharmaceutical and nutraceutical applications.
  • Product ORODISPERSIBLE FILMS (ODF)

    Orodispersible films (ODF) constitute an innovative oral drug delivery system. 

    This dosage form is placed on patient's tongue or oral mucosal tissue and it rapidly dissolves to release the API for mucosal and sublingual absorption. As the film dissolves, the drug enters the blood strea...
  • Product ORALLY DISINTEGRATING TECHNOLOGY

    Designed to disintegrate rapidly on contact with saliva and enable oral administration without water or chewing. This kind of formulation offer increased convenience and ease of administration with the potential to improve compliance, particularly in certain populations where swallowing conventional solid ...
  • Product Syntegon SVP Process System

    The highly modular and standardized system solution providing the highest degree of flexibility in both the layout of the customer's room concept and the configuration of the production units themselves. Over 70 pre-tested functional modules are available to process batch sizes from 13 to 3,000 liters.
  • Product Nanosol

    NanoSol is a technology for the production of nano-sized drug particles. Formulation of a drug substance in nano-particle form significantly increases the surface area available for dissolution.  A ten-to-twenty-fold increase in surface area can result from reducing particle size from a micronized dru...
  • Product Microcaps® Taste Masking and Modified Release Technology

    Microcaps® Taste Masking and Modified Release Technology achieves uniform and efficient coating of drug particles by coacervation (phase separation) to build polymeric membranes of varying porosity and thickness. The result is a free-flowing powder containing microencapsulated API (or API substrate) in a w...
  • Product Investigational Medicinal Product Manufacture

    Nordmark Arzneimittel GmbH & Co. KG provides a wide range of services, including the manufacture of investigational medicinal products (IMP), in particular based on biological APIs. Capability to produce microbiom IMP under anaerobic conditions. Contact us for more information.
  • Product Formulation Development

    KBI's approach to formulation development is based on the strategic pairing of two complementary scientific disciplines:
    • Establishing a comprehensive understanding of the thermal, physical, chemical, and conformational stability. • Employing statistical design-of-experiment (DOE) to evaluate main ef...
  • Product MedSpray technology

    MedSpray is a patented aerosol-based system developed by MedPharm for a range of applications. Known as a “patch-in-a-can”, MedSpray delivers the selected API onto the skin or other tissue surface. It is thermodynamically-optimized to maximize permeation and penetration of the API through the tissue, and u...
  • Product Formulation Development

    From preclinical and first-in-human (FIH) dosage forms to optimization of your drug product for late-stage development and market following clinical evaluation, we work with you to develop the most appropriate formulation based on the physicochemical and biopharmaceutics properties of your drug molecule, t...
  • Product Pre-Formulation Services

    A wide range of IND enabling drug product services are provided at Eurofins CDMO. Our PhD scientists have extensive experience in material characterization, analytical chemistry and strategies for developing poorly soluble compounds. Our Pre-Formulation laboratory is fitted with a suite of specialized equi...
  • Product E.SOLVE | SOLVING BIOAVAILABILITY CHALLENGES

    E.SOLVE accelerates your journey to the clinic supporting as early as possible your formulation strategy from discovery to market approval.
    · When you deal with a challenging API, partner with Evotec's screening experts to guide your process through every challenge along the drug discovery and devel...
  • Product Co-Processed excipients for ODT (GRANFILLER-D®, HiSORAD™, SmartEx™)

    Your benefits
    - Ready-to-use mixture (filler, disintegrant, optionally taste masking)
    - fast API release
    - co-processed excipients with improved properties compared to physical mixtures

    Applications
    - Orally dispersible tablets (O...
  • Product GINESTRA®

    GINESTRA is a medical device class IIA in the form of vaginal tablets to be used in all cases of temporary alteration of the balance of the urovaginal ecosystem.